【结 构 式】 |
【药物名称】Pantoprazole sodium, DZ-2352a, B-8510-29(free acid), By-1023/SK&F-96022(free acid), B-8610-23/SK&F-96022-Z, Pantorc, Rifun, Pantozol, Zurcal, Ulcotenal, Inipomp, Pantecta, Anagastra, Pantoloc, Pantopan, Inipomp, Peptazol, Protonix, Protium 【化学名称】5-(Difluoromethoxy)-2-(3,4-dimethoxypyridin-2-ylmethylsulfinyl)-1H-benzimidazole sodium salt 【CA登记号】138786-67-1, 102625-70-7 (free acid), 164579-32-2 (sesquihydrate) 【 分 子 式 】C16H14F2N3NaO4S 【 分 子 量 】405.35828 |
【开发单位】Altana Pharma (Originator), Recordati (Not Determined), Abbott (Licensee), Daiichi Pharmaceutical (Licensee), Madaus (Licensee), Nycomed Pharma (Licensee), Pfizer (Licensee), Ravizza (Licensee), Roche (Licensee), Sanofi-Synthélabo (Licensee), Schwarz (Lic 【药理作用】Anti-Helicobacter Pylori Agents, Antiulcer Drugs, Esophageal Diseases, Treatment of, Gastric Antisecretory Drugs, Gastroesophageal Reflux Disease, Agents for, GASTROINTESTINAL DRUGS, H+/K+-ATPase Inhibitors |
合成路线1
【1】 Mukarram J, Mohammed S, Naithani PK, et aL 2007. Process for the preparation of pantoprazole and related compounds via oxidation of the corresponding thioethers. W0 2007026188(本专利属于Wockhardt Limited, India) |
合成路线2
【1】 Palomo Nicolau F, Molina Ponce A. 2006. Metboxylation process for the preparation of pantoprazole. WO 2006100243(本专利属于Quimica Sintetica,S A, Spain) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56508 | 4-chloro-2-({[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl}methyl)-3-pyridinyl methyl ether; 2-{[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfanyl}-5-(difluoromethoxy)-1H-benzimidazole | C15H12ClF2N3O2S | 详情 | 详情 |
合成路线3
【1】 Lieberman A, Singer C,RaiziY. 2004. A process for preparing 2-[ (pyridinyl) methyl] sulfinyl-substituted benzimidazoles and its novel chlorinated derivatives, useful as inhibitors of gastric acid sectetion. WO 2004111029(本专利属于Teva Phttrmaceutical Industries Ltd, Israel; Teva Pharmaceuticals Usa, Inc) |
【2】 Kohl B. Mueller B,Weingart RS. 2004. A process for preparing (S)-pantoprazole via stereaselective oxidn. of pyridinylmethylsulfinylbenzimidazole deriv. in the presence of L-tartaric acid deriv. and chiral zircoruum or hafnium catalyst. W0 2004052881(本专利属于Altana Pharma Ag, Germany) |
合成路线4
【1】 Kankan RN, Rao DR, Srinivas PL. 2004. Method for the preparation of pyndinylmethylsulfinylbenzimidazoles which are substantially free of oxidation contaminants for use in pharmaceutical compositions for treatment of gastric ulcers. W0 2004063188(本专利属于Cipla Limited, India;Wain,Christopher Paul) |
合成路线5
【1】 Avrutov I. Mendelovici M, Finkelstein N. 2004. Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-lH-benzimidazoles. US 2004138466 |
合成路线6
【1】 Modi PA, Motiwala JK, Durlabhaji C. 1997. A process for the manufacture of 5-(difluorometboxy)-2- [[ (3,4-dimethoxy-2-pyridinyl methyl] sulfinyl] -lH-benzimidazole, i, e, the antiulcer agent pantoprazole, via oxidation of its thio analog. IN 179805(本专利属于Unichem Laboratories Ltd.India) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 66569 | 5-(difluoromethoxy)-1H-benzo[d]imidazole-2(3H)-thione | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
(II) | 14035 | 2-(Chloromethyl)-3,4-dimethoxypyridine; 2-(Chloromethyl)-3-methoxy-4-pyridinyl methyl ether | 72830-09-2 | C8H10ClNO2 | 详情 | 详情 |
(III) | 14036 | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole; 2-([[5-(Difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl]methyl)-3-methoxy-4-pyridinyl methyl ether | 102625-64-9 | C16H15F2N3O3S | 详情 | 详情 |
合成路线7
【1】 Avrutov I.Mendelovici M. 2002. Processes for the production of substituted 2-(2-pyridinylmethyl) sulfinyl-lH-benzimidazoles using tert-butyl hydmpermade or oxone. W0 2002062786(本专利属于Teva Pharmaceutical Industries Ltd. Israel; Teva Pharmaceutical USA, Inc) |
合成路线8
【1】 Palomo Coll A. 2002. A process for the preparation of pantoprazole and intermediates thereof. WO 2002028852(本专利属于Dmamite Dipharma, Italy) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56506 | 4-chloro-3-methoxy-2-methyl-1-pyridiniumolate | C7H8ClNO2 | 详情 | 详情 | |
(II) | 56510 | (4-chloro-3-methoxy-2-pyridinyl)methanol | C7H8ClNO2 | 详情 | 详情 | |
(III) | 56511 | 4-chloro-2-(chloromethyl)-3-methoxypyridine; 4-chloro-2-(chloromethyl)-3-pyridinyl methyl ether | C7H7Cl2NO | 详情 | 详情 | |
(IV) | 66569 | 5-(difluoromethoxy)-1H-benzo[d]imidazole-2(3H)-thione | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
(V) | 56508 | 4-chloro-2-({[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl}methyl)-3-pyridinyl methyl ether; 2-{[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfanyl}-5-(difluoromethoxy)-1H-benzimidazole | C15H12ClF2N3O2S | 详情 | 详情 | |
(VI) | 56508 | 4-chloro-2-({[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl}methyl)-3-pyridinyl methyl ether; 2-{[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfanyl}-5-(difluoromethoxy)-1H-benzimidazole | C15H12ClF2N3O2S | 详情 | 详情 |
合成路线9
【1】 Coppi L,Berenguer Maimo R. 2001. Method for obtaining derivatives of[[(substituted-pyridyl) methyl] thio] benzimidazole, useful as intermediates for omeprazole and related antiulcer agents. W0 2001079194 (本专利属于Esteve Quimica,S A, Spain) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56506 | 4-chloro-3-methoxy-2-methyl-1-pyridiniumolate | C7H8ClNO2 | 详情 | 详情 | |
(II) | 56507 | (4-chloro-3-methoxy-2-pyridinyl)methyl methanesulfonate | C8H10ClNO4S | 详情 | 详情 | |
(III) | 66569 | 5-(difluoromethoxy)-1H-benzo[d]imidazole-2(3H)-thione | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
(IV) | 56508 | 4-chloro-2-({[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl}methyl)-3-pyridinyl methyl ether; 2-{[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfanyl}-5-(difluoromethoxy)-1H-benzimidazole | C15H12ClF2N3O2S | 详情 | 详情 |
合成路线10
A new synthesis of [14C]-labeled pantoprazole has been described: The cyclization of potassium [14C]-ethylxanthate (I) with the diaminobenzene (II) by means of NaOH gives the imidazole (III), which is condensed with 2-(chloromethyl)-3,4-dimethoxypyridine (IV) by means of NaOH in ethanol to afford the sulfide (V). Finally, this compound is oxidized with m-chloroperbenzoic acid (mcpba) in dichloromethane.
【1】 Saunders, D.; Lawrie, K.W.M.; Crowe, A.M.; Johnston, C.E.A.; The synthesis of [14C]pantoprazole - SK&F 96022Z - An H+/K+ ATP inhibitor. J Label Compd Radiopharm 1992, 31, 5, 409. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14032 | Dithiocarbonic acid O-ethyl ester potassium salt | C3H5KOS2 | 详情 | 详情 | |
(I) | 45190 | potassium 1-(carbodithioatooxy)ethane | C3H5KOS2 | 详情 | 详情 | |
(II) | 14033 | 4-(Difluoromethoxy)-1,2-benzenediamine; 2-Amino-4-(difluoromethoxy)phenylamine | C7H8F2N2O | 详情 | 详情 | |
(III) | 14034 | 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol; 5-(Difluoromethoxy)-1H-benzimidazol-2-ylhydrosulfide; 5-Difluoromethoxy-2-mercapto-1H-benzimidazole | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
(III) | 45191 | 5-(difluoromethoxy)-1H-benzimidazole-2-thiol; 5-(difluoromethoxy)-1H-benzimidazol-2-ylhydrosulfide | C8H6F2N2OS | 详情 | 详情 | |
(IV) | 14035 | 2-(Chloromethyl)-3,4-dimethoxypyridine; 2-(Chloromethyl)-3-methoxy-4-pyridinyl methyl ether | 72830-09-2 | C8H10ClNO2 | 详情 | 详情 |
(V) | 14036 | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole; 2-([[5-(Difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl]methyl)-3-methoxy-4-pyridinyl methyl ether | 102625-64-9 | C16H15F2N3O3S | 详情 | 详情 |
(V) | 45192 | 2-([[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl]methyl)-3-methoxy-4-pyridinyl methyl ether; 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole | C16H15F2N3O3S | 详情 | 详情 |
合成路线11
Using [14C]-labeled (IV) in the preceding synthesis, pantoprazole labeled in the methylene was obtained. Intermediate (IV) labeled in the methylene attached to the pyridine ring can be prepared as follows: The reaction of 2-bromo-3,4-dimethoxypyridine (V) with [14C]-labeled CuCN gives 3,4-dimethoxypyridine-2-carbonitrile (VI), which is hydrolyzed with NaOH and methylated with diazomethane to the methyl ester (VII). Finally, this compound is reduced with LiAlH4 to the corresponding alcohol and treated with SOCl2 to give the chloromethylpyridine (IV*) with the [14C] label. Then this compound is condensed with benzimidazole (III) as usual.
【1】 Saunders, D.; Lawrie, K.W.M.; Crowe, A.M.; Johnston, C.E.A.; The synthesis of [14C]pantoprazole - SK&F 96022Z - An H+/K+ ATP inhibitor. J Label Compd Radiopharm 1992, 31, 5, 409. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IV) | 14035 | 2-(Chloromethyl)-3,4-dimethoxypyridine; 2-(Chloromethyl)-3-methoxy-4-pyridinyl methyl ether | 72830-09-2 | C8H10ClNO2 | 详情 | 详情 |
(IV) | 45195 | 2-(chloromethyl)-3-methoxy-4-pyridinyl methyl ether; 2-(chloromethyl)-3,4-dimethoxypyridine | C8H10ClNO2 | 详情 | 详情 | |
(V) | 14037 | 2-Bromo-3-methoxy-4-pyridinyl methyl ether; 2-Bromo-3,4-dimethoxypyridine | C7H8BrNO2 | 详情 | 详情 | |
(VI) | 14038 | 3,4-Dimethoxy-2-pyridinecarbonitrile | C8H8N2O2 | 详情 | 详情 | |
(VI) | 45193 | 3,4-dimethoxy-2-pyridinecarbonitrile | C8H8N2O2 | 详情 | 详情 | |
(VII) | 14039 | methyl 3,4-dimethoxy-2-pyridinecarboxylate | C9H11NO4 | 详情 | 详情 | |
(VII) | 45194 | methyl 3,4-dimethoxy-2-pyridinecarboxylate | C9H11NO4 | 详情 | 详情 |
合成路线12
The precursor 5-(difluoromethoxy)-2-mercaptobenzimidazole (V) was prepared by the following route. Nitration of N-(p-difluoromethoxyphenyl)acetamide (I) provided nitro anilide (II), which was hydrolyzed to the corresponding nitro aniline (III) employing methanolic NaOMe. Reduction of (III) to the phenylenediamine (IV) was performed by catalytic hydrogenation over Pd/C. Then, cyclization of diamine (IV) with potassium O-ethyl dithiocarbonate gave rise to the benzimidazole (V).
【1】 Kohl, B.; Sturm, E.; Klemm, K.; Riedel, R.; Figala, V.; Rainer, G.; Schaefer, H.; Senn-Bilfinger, J. (Altana Pharma Deutschland GmbH ); Dialkoxypyridines, process for their preparation, their use and medicines containing them. AU 8543640; EP 0166287; JP 1986022079; US 4758579 . |
【2】 Rainer, G.; Riedel, R.; Senn-Bilfinger, J.; Klemm, K.; Schaefer, H.; Figala, V. (Altana Pharma Deutschland GmbH ); Antisecretory substd. pyridylmethylthio-(or sulfinyl)benzimidazoles. EP 0134400; JP 1984206379; JP 1993086037; US 4555518 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56493 | N-[4-(difluoromethoxy)phenyl]acetamide | C9H9F2NO2 | 详情 | 详情 | |
(II) | 56494 | N-[4-(difluoromethoxy)-2-nitrophenyl]acetamide | C9H8F2N2O4 | 详情 | 详情 | |
(III) | 56495 | 4-(difluoromethoxy)-2-nitroaniline; 4-(difluoromethoxy)-2-nitrophenylamine | C7H6F2N2O3 | 详情 | 详情 | |
(IV) | 14033 | 4-(Difluoromethoxy)-1,2-benzenediamine; 2-Amino-4-(difluoromethoxy)phenylamine | C7H8F2N2O | 详情 | 详情 | |
(V) | 14034 | 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol; 5-(Difluoromethoxy)-1H-benzimidazol-2-ylhydrosulfide; 5-Difluoromethoxy-2-mercapto-1H-benzimidazole | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
合成路线13
3-Methoxy-2-methylpyridine (VII), prepared by methylation of 2-methyl-3-pyridinol (VI), was converted to the N-oxide (VIII) employing peracetic acid. Nitration of the pyridine N-oxide (VIII) with concentrated nitric acid gave the 4-nitro derivative (IX). Subsequent displacement of the nitro group of (IX) by sodium methoxide led to the dimethoxypyridine N-oxide (X). Rearrangement of the N-oxide group of (X) in hot acetic anhydride produced the acetoxymethyl pyridine (XI). After basic hydrolysis of the acetate ester (XI), the resultant hydroxymethyl pyridine (XII) was chlorinated by SOCl2, yielding chloride (XIII). Condensation between mercapto benzimidazole (V) and the chloromethyl pyridine (XIII) in ethanolic NaOH led to the sulfide adduct (XIV). This was finally oxidized to the desired sulfoxide by using meta-chloroperbenzoic acid in CH2Cl2. The oxidation of sulfide (XIV) has also been performed employing sodium perborate, sodium percarbonate in the presence of ammonium molybdate, or tert-butyl hydroperoxide in the presence of vanadyl acetylacetonate.
【1】 Coppi, L.; Berenguer Maimó, R. (Laboratorios del Dr. Esteve, SA); Method for obtaining derivs. of [[pyridyl substd.)methyl]thio]benzimidazol. ES 2171116; WO 0179194 . |
【2】 Mendelovici, M.; Avrutov, I. (Teva Pharmaceutical Industries Ltd.; Teva Pharmaceuticals USA, Inc.); Processes for the production of substd. 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles. WO 0262786 . |
【3】 Coppi, L.; Campon Pardo, J.; Berenguer Maimo, R. (Laboratorios del Dr. Esteve, SA); Method for oxidizing a thioether group into a sulfoxide group. ES 2163372; WO 0168594 . |
【4】 Brennan, J.P.; Turner, A.T. (Abbott Laboratories Inc.); Chemical process for the production of sulphinyl derivs. by oxidation of the corresponding co-derivs. with perborates. WO 9947514 . |
【5】 Kohl, B.; Sturm, E.; Senn-Bilfinger, J.; Simon, W.A.; Krüger, U.; Schaefer, H.; Rainer, G.; Figala, V.; Klemm, K.; (H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate. J Med Chem 1992, 35, 6, 1049. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 14034 | 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol; 5-(Difluoromethoxy)-1H-benzimidazol-2-ylhydrosulfide; 5-Difluoromethoxy-2-mercapto-1H-benzimidazole | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
(VI) | 29609 | 2-methyl-3-pyridinol | 1121-25-1 | C6H7NO | 详情 | 详情 |
(VII) | 56496 | 3-methoxy-2-methylpyridine; methyl 2-methyl-3-pyridinyl ether | C7H9NO | 详情 | 详情 | |
(VIII) | 56497 | 3-methoxy-2-methyl-1-pyridiniumolate | C7H9NO2 | 详情 | 详情 | |
(IX) | 56498 | 3-methoxy-2-methyl-4-nitro-1-pyridiniumolate | C7H8N2O4 | 详情 | 详情 | |
(X) | 56499 | 3,4-dimethoxy-2-methyl-1-pyridiniumolate | C8H11NO3 | 详情 | 详情 | |
(XI) | 56500 | (3,4-dimethoxy-2-pyridinyl)methyl acetate | C10H13NO4 | 详情 | 详情 | |
(XII) | 56501 | (3,4-dimethoxy-2-pyridinyl)methanol | C8H11NO3 | 详情 | 详情 | |
(XIII) | 14035 | 2-(Chloromethyl)-3,4-dimethoxypyridine; 2-(Chloromethyl)-3-methoxy-4-pyridinyl methyl ether | 72830-09-2 | C8H10ClNO2 | 详情 | 详情 |
(XIV) | 14036 | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole; 2-([[5-(Difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl]methyl)-3-methoxy-4-pyridinyl methyl ether | 102625-64-9 | C16H15F2N3O3S | 详情 | 详情 |
合成路线14
A related method for the preparation of the intermediate 3,4-dimethoxy-2-(hydroxymethyl)pyridine (XII) has been disclosed. 3-Methoxypyridine (XV) was chlorinated to (XVI) by refluxing in SOCl2. Radical carboxylation of pyridine (XVI) was carried out by reaction with ethyl pyruvate in the presence of hydrogen peroxide and iron(II) sulfate. The resultant ethyl 4-chloro-3-methoxypicolinate (XVII) was then converted to the dimethoxypicolinate (XVIII) by treatment with sodium methoxide. Then, ester group reduction in (XVIII) by means of DIBAL provided the target hydroxymethyl pyridine (XII).
【1】 Chen, L.; Zoghbi, M. (PDi-Research Laboratories, Inc. ); Synthesis of pharmaceutically useful pyridine derivs.. WO 9850361 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XII) | 56501 | (3,4-dimethoxy-2-pyridinyl)methanol | C8H11NO3 | 详情 | 详情 | |
(XV) | 56502 | 3-Methoxypyridine | 7295-76-3 | C6H7NO | 详情 | 详情 |
(XVI) | 56503 | 4-chloro-3-methoxypyridine; 4-chloro-3-pyridinyl methyl ether | C6H6ClNO | 详情 | 详情 | |
(XVII) | 56504 | ethyl 4-chloro-3-methoxy-2-pyridinecarboxylate | C9H10ClNO3 | 详情 | 详情 | |
(XVIII) | 14039 | methyl 3,4-dimethoxy-2-pyridinecarboxylate | C9H11NO4 | 详情 | 详情 |
合成路线15
In an alternative procedure, the nitropyridine N-oxide (IX) was rearranged to the (mesyloxymethyl)pyridine (XIX) by treatment with methanesulfonic anhydride. Condensation of mesylate (XIX) with mercaptobenzimidazole (V), with concomitant nitro group displacement in the presence of sodium methoxide led to the sulfide precursor (XIV). This was then oxidized to the title sulfoxide employing sodium percarbonate and ammonium molybdate. An analogous synthetic route starting from the chloropyridine N-oxide (XX) provided mesylate (XXI), which was condensed with (V) in the presence of Et3N, leading to the sulfide adduct (XXII). The 4-chloro group of (XXII) was then displaced by sodium methoxide producing the dimethoxypyridine derivative (XIV).
【1】 Coppi, L.; Berenguer Maimó, R. (Laboratorios del Dr. Esteve, SA); Method for obtaining derivs. of [[pyridyl substd.)methyl]thio]benzimidazol. ES 2171116; WO 0179194 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 14034 | 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol; 5-(Difluoromethoxy)-1H-benzimidazol-2-ylhydrosulfide; 5-Difluoromethoxy-2-mercapto-1H-benzimidazole | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
(IX) | 56498 | 3-methoxy-2-methyl-4-nitro-1-pyridiniumolate | C7H8N2O4 | 详情 | 详情 | |
(XIV) | 14036 | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole; 2-([[5-(Difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl]methyl)-3-methoxy-4-pyridinyl methyl ether | 102625-64-9 | C16H15F2N3O3S | 详情 | 详情 |
(XIX) | 56505 | (3-methoxy-4-nitro-2-pyridinyl)methyl methanesulfonate | C8H10N2O6S | 详情 | 详情 | |
(XX) | 56506 | 4-chloro-3-methoxy-2-methyl-1-pyridiniumolate | C7H8ClNO2 | 详情 | 详情 | |
(XXI) | 56507 | (4-chloro-3-methoxy-2-pyridinyl)methyl methanesulfonate | C8H10ClNO4S | 详情 | 详情 | |
(XXII) | 56508 | 4-chloro-2-({[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl}methyl)-3-pyridinyl methyl ether; 2-{[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfanyl}-5-(difluoromethoxy)-1H-benzimidazole | C15H12ClF2N3O2S | 详情 | 详情 |
合成路线16
Similarly, rearrangement of the chloropyridine N-oxide (XX) using acetic anhydride produced acetate ester (XXIII), which was further hydrolyzed to the pyridine alcohol (XXIV). The chloromethyl pyridine (XXV), obtained by treatment of alcohol (XXIV) with SOCl2, was condensed with the mercaptobenzimidazole (V) in the presence of tetramethylguanidine producing sulfide (XXII). Conversion of (XXII) to the title compound was then performed by oxidation to sulfoxide (XXVI) employing sodium percarbonate, followed by chloride displacement with potassium methoxide.
【1】 Palomo Coll, A.; A process for the preparation of pantoprazole and intermediates therefor. WO 0228852 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 14034 | 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol; 5-(Difluoromethoxy)-1H-benzimidazol-2-ylhydrosulfide; 5-Difluoromethoxy-2-mercapto-1H-benzimidazole | 97963-62-7 | C8H6F2N2OS | 详情 | 详情 |
(XX) | 56506 | 4-chloro-3-methoxy-2-methyl-1-pyridiniumolate | C7H8ClNO2 | 详情 | 详情 | |
(XXII) | 56508 | 4-chloro-2-({[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfanyl}methyl)-3-pyridinyl methyl ether; 2-{[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfanyl}-5-(difluoromethoxy)-1H-benzimidazole | C15H12ClF2N3O2S | 详情 | 详情 | |
(XXIII) | 56509 | (4-chloro-3-methoxy-2-pyridinyl)methyl acetate | C9H10ClNO3 | 详情 | 详情 | |
(XXIV) | 56510 | (4-chloro-3-methoxy-2-pyridinyl)methanol | C7H8ClNO2 | 详情 | 详情 | |
(XXV) | 56511 | 4-chloro-2-(chloromethyl)-3-methoxypyridine; 4-chloro-2-(chloromethyl)-3-pyridinyl methyl ether | C7H7Cl2NO | 详情 | 详情 | |
(XXVI) | 56512 | (4-chloro-3-methoxy-2-pyridinyl)methyl 5-(difluoromethoxy)-1H-benzimidazol-2-yl sulfoxide; 2-{[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfinyl}-5-(difluoromethoxy)-1H-benzimidazole | C15H12ClF2N3O3S | 详情 | 详情 |